Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

Here is why it could be a smart buy now. Not every stock needs to be a millionaire-maker. Sometimes, slow and steady can win ...

These five well-known dividend stocks were beaten down in the recent selling but will remain attractive long after the tariff ...

Pfizer stock fell to the lowest closing price since 2012, putting its yield near 8%, after cautious comments from a UBS ...

UBS analyst Trung Huynh lowered the firm’s price target on Pfizer (PFE) to $24 from $28 and keeps a Neutral rating on the shares. The firm says ...

Goldman Sachs downgraded Pfizer (PFE) to Neutral from Buy with a price target of $25, down from $32, after assuming coverage of the name. The ...